LINC00941 and pachyonychia congenita: LINC00941 has been studied in various GI cancer types, including squamous cell carcinoma (ESCC) 35, 39, gastric cancer (GC) 45, 46, colorectal cancer (CRC) 41, 44, hepatocellular carcinoma (HCC) 47, and pancreatic cancer (PC) 36, 37, 40, 42, 43, 48, 49.